WeVote

Bill

Bill

A 5673

"Gary Letizia Pre-Hospital Blood Transfusion Act"; authorizes paramedics, under medical oversight, to administer blood products to patients in pre-hospital settings, and establishes certain reimbursement for emergency medical services providers.

2024-2025 Regular Session Introduced by Bob Auth and 3 co-sponsors

New Jersey authorizes paramedics to administer blood products in pre-hospital emergency settings under medical oversight and establishes EMS reimbursement for this service.

Introduced in the Assembly, Referred to Assembly Health Committee
0
WeVote Research Nonpartisan
Bill Summary · A 5673

Legislative bill overview

This New Jersey bill authorizes paramedics and emergency medical services (EMS) providers to administer blood products to patients in pre-hospital settings—before patients reach hospitals—under established medical protocols and physician oversight. The legislation also creates a reimbursement mechanism for EMS providers who deliver this expanded service, likely through insurance or state funding sources.

Why is this important

Administering blood products in the field can be critical for trauma patients experiencing severe hemorrhage, potentially preventing death or permanent injury during transport to hospitals. Currently, this lifesaving intervention is typically unavailable until patients arrive at emergency departments, which can mean delays of 20+ minutes in rural or congested areas. Establishing legal authority and reimbursement removes barriers to implementing this practice and may save lives in time-sensitive situations.

Potential points of contention

  • Medical safety and training standards: Questions about what training paramedics need, how blood products are stored/transported safely, and protocols for determining patient eligibility in field conditions without full diagnostic information
  • Blood product supply and logistics: Concerns about maintaining cold chains, inventory costs, potential waste, and coordination with blood banks and hospitals
  • Cost and reimbursement disputes: Debate over who bears costs (insurers, state budget, EMS agencies) and whether reimbursement rates adequately cover expenses or create unfunded mandates
  • Liability and oversight mechanisms: Clarity needed on medical director authority, malpractice liability, and adverse event reporting requirements

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.